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PURPOSE: This was a retrospective cohort study aiming to investigate the clinical outcome of patients with intermittent claudication
undergoing physical training in whom there was an aggravation of the arterial disease.
METHOD: Three hundred and sixty-four patients with claudication who presented with femoropopliteal or tibioperoneal
obstructions in at least 1 of the lower limbs and who did not have aortic or bilateral iliac obstructions were included. Forty patients
developed new stenoses in previously spared arterial segments (confirmed by duplex scanning), which were proximal to preexisting
lesions, and formed the progression group, in contrast to the stable group of patients (n = 324) who did not exhibit this worsening
of the disease. Follow-up was 276 and 277 days for stable and progression groups, respectively. All patients underwent an
unsupervised program of submaximal walking 4 days a week. Changes in maximal walking distance at a progressive treadmill
test were appraised during follow-up, with special interest directed to the periods between admission, diagnosis of arterial worsening,
and the end of follow-up.
RESULTS: Performance was not significantly different between groups during the entire follow-up period. Furthermore, patients
with claudication who evolved with progression of their arteriopathy did not present a reduction of their maximal walking distance
in response to the development of new arterial lesions at any time during their follow-up.
CONCLUSION: Worsening of the peripheral arterial disease in patients with claudication undergoing physical training, manifested
as de novo arterial occlusion in proximal and previously spared segments, does not imply in an impairment of their claudication
distance.
KEYWORDS: Intermittent claudication. Treatment outcome. Exercise therapy. Disease progression. Peripheral arterial
disease.
INTRODUCTION
Intermittent claudication is one of the most common
clinical manifestations of lower limb ischemia. Patients
with intermittent claudication may have major functional
deficits, with repercussions for their quality of life. Clini-
cal treatment based on physical training and controlling the
risk factors for atherosclerosis is the preferred therapeutic
approach, with good results when adequately performed.1
The main cause of intermittent claudication is atheroscle-
rosis, a disease that frequently affects different arterial lev-
els, and not always at the same time.
For this reason, it is possible to find in the lower limbs
involved by the arteriopathy the emergence of new arte-
rial lesions in proximal and previously spared segments.
Although the anatomopathological evolution of preexistent
stenoses of the superficial femoral artery has already been
well documented,2 the clinical repercussions of the wors-
ening of the arterial disease in the manner described above
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relative to claudication distance are not yet well established.
While an impairment in claudication distance perform-
ance would be expected in this setting, which is encoun-
tered rather frequently in a physician’s daily work, the only
published study was limited by a small sample size and in-
adequate assessment of outcome variables.3
Thus, the objective of this investigation was to deter-
mine the influence of the progression of the arteriopathy
to proximal and previously spared segments on the claudi-
cation distance in patients undergoing to physical training.
METHODS
This was a retrospective cohort study. Among patients
with intermittent claudication admitted during the period
between July 1994 and December 2002, we selected those
who presented femoropopliteal or tibioperoneal obstruc-
tions in at least 1 of the lower limbs and who did not have
aortic or bilateral iliac obstruction. There was no bias in
patient admission, since participants come directly from the
community, without previous referral. All patients under-
went similar treatment following the same protocol with
the approval of of the university’s ethics committee for the
analysis of research projects involving experimentation on
human beings, in harmony with the Helsinki Declaration
of 1975, as revised in 1989. All participants gave written
informed consent.
Patients with other disorders that were more severe than
intermittent claudication, such as neuropathy, heart failure,
and fracture, were not included, neither were those with
severe ischemia at the first clinical evaluation (gangrene
or ischemic pain while at rest).
An unsupervised program of physical activity, consist-
ing of walking for 40 minutes per day, 4 times a week, was
prescribed. Patients were instructed to continue to walk af-
ter the onset of typical pain but to stop before the pain
reached its maximum intensity. At this point, patients were
to rest until the pain subsided and then start walking again
to complete the time required. In face-to-face follow-up
visits, patients were carefully instructed about the benefits
of exercise training. Patients were likewise encouraged to
stop smoking and were instructed about the benefits of do-
ing so. No patient was given any type of pharmacologic
therapy, but those who were on antiplatelet agents for treat-
ment of cardiac diseases were instructed to continue this
therapy. All patients were assessed at admission and in com-
prehensive visits at months 3 and 6 and at 6-month inter-
vals thereafter.
The ankle-brachial index was evaluated in all patients
on entry by Doppler ultrasound (model 1050-C Vascular
Mini-Lab, Parks Medical Electronics, Aloha, Oregon).
Maximal walking distance (MWD, also termed claudi-
cation distance), the distance walked until claudication pain
prevented further walking, was determined on entry and in
all serial visits in a progressive treadmill test on a motor-
ized treadmill (Trimline, Hebb Industries, Whitehouse,
Texas). This test was carried out at a constant velocity of
3.2 km/h, initially on a level surface (0o incline) and then
with a progressive increase of 2% in the incline every 2
minutes.4
The extent of arterial disease was appraised by physi-
cal examination (palpation of arterial pulses) in all visits,
and confirmed by color duplex scanning (model SSH140A,
Toshiba, Shibaura, Japan) with transducers of 3.5, 5.0, and
7.5 MHz on entry and when a significant change in the
pulse pattern was detected by at least 2 examiners.
Progression of peripheral arterial disease was confirmed
when previously spared arterial segments that were proxi-
mal to preexisting lesions presented stenoses or occlusions.
This procedure enabled the determination of 2 different
groups of patients: those who evolved with the progression
of the peripheral arterial disease (progression group; n =
40) and those whose disease remained stable (stable group;
n = 324).
For the patients of the progression group, the follow-
ing variables were calculated:
• Delta 1: MWD measured at the last follow-up visit mi-
nus MWD measured immediately before the confirma-
tion of the progression;
• Delta 2: MWD measured at the last follow-up visit mi-
nus MWD measured immediately after the confirma-
tion of the progression;
• Delta 3: MWD measured immediately after minus
MWD measured immediately before the confirmation
of the progression.
The following variable was calculated for the patients
of the stable group:
• Delta 1: MWD measured at the last follow-up visit mi-
nus MWD measured at entry
Medians and interquartile ranges of the variables de-
scribed above were calculated. For comparisons of the ob-
served results between groups, the Wilcoxon-Mann-
Whitney test was used. For comparisons of data regarding
exclusively the progression group, the Kruskal-Wallis
(nonparametric ANOVA) test was used. The value of 5%
was adopted as the level of statistical significance.
RESULTS
Three hundred sixty-four patients were selected for this
investigation. Table 1 shows the demographic data of both
groups of patients. Of special interest is the fact that the pro-
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portion of men in the progression group was significantly
lower than in the stable group. On the other hand, mean age
and follow-up length were similar between both groups.
Table 2 shows the results of the variations of the MWD
measured at different follow-up times, as described above.
There was no significant difference in the values of Delta
1 between groups.
Furthermore, there was no significant difference be-
tween Deltas 1, 2, and 3 regarding the progression group.
DISCUSSION
The results of the present study demonstrate that the
worsening of the peripheral arterial disease in claudicanting
patients undergoing physical training, manifested as de
novo arterial occlusion in proximal and previously spared
segments, does not imply in an impairment of their clau-
dication distance. Indeed, claudicants who evolved with
progression of their arteriopathy did not present reductions
of their maximal walking distance in response to the de-
velopment of new arterial lesions at any time of their fol-
low-up. This becomes evident when we compare the meas-
urements of MWD immediately after the confirmation of
the progression, or even at the last follow-up visit, against
MWD measurements made before that confirmation.
The natural history of the walking distance of patients with
intermittent claudication is already well documented. There
is a consensus that approximately 25% of those patients
present a significant impairment at any time of their lives. This
happens in the first year after diagnosis in 7.5% of the cases
and in each of the subsequent years in 2.2% of the cases1,5
In quantitative terms, Aquino R, et al,6 studying the
natural history of 1244 claudicants for a mean follow-up
of 45 months, observed an average reduction in the walk-
ing distance reported by the patient (a nonobjective meas-
urement) of approximately 8 meters per year.
The natural history of intermittent claudication is sig-
nificantly changed when these patients undergo physical
training, the benefits of which have already been suffi-
ciently documented. A previous study by our group showed
that claudicants who adequately adhere to unsupervised
physical training evolve with substantial and predictable
improvements.7
The progression of the atherosclerotic lesions in
claudicants is a neglected theme. The aggravation of pre-
viously existing lesions has been well studied in coronary
arteries, and it has also been investigated in the lower limbs.
Walsh et al,2 observed a worsening of superficial femoral
artery stenoses in only 28% and occlusion in only 17% of
the cases in a follow-up period of 37 months. On the other
hand, the clinical repercussion of the worsening of this ar-
terial disease has been little addressed until now. A study
with 19 claudicants who had femoropopliteal occlusion
showed progression of their arteriopathy in 14. Among
those, only 2 evolved with an impairment in their maxi-
mal walking distance.3 However, it is not clear in that in-
vestigation how the patients were treated and the method
of measurement of MWD.
All the mechanisms involved in the improvement of the
claudication distance after exercise could explain the good
results seen with patients in the progression group; mus-
cular enzymatic and hemorheologic changes possibly play
a major role in this context,8,9 as might biomechanical ad-
aptations in the patient gait.10,11 Thus, when the aggrava-
tion of the arterial disease occurs, the muscle groups af-
fected by the ensuing ischemia would be sufficiently trained
to tolerate a lower oxygen supply and maintain their per-
formance unaltered in relation to this event. Clinically, such
a situation would have little or no expression.
In conclusion, in light of the results of the present study,
it is possible to state that the evolution of claudicants un-
dergoing unsupervised physical training who present a
worsening of the arterial disease in their lower limbs char-
acterized by a de novo occlusion in proximal and previ-
ously spared segments is benign and similar to that ob-
served in patients whose arterial disease remains stable.
Consequently, claudicants with signs of progression of their
arteriopathy without manifestations of critical ischemia
should not necessarily be considered for invasive treatment
and may continue to receive conservative treatment. Un-
derstandably, clinical surveillance over those patients
should be implemented, not only regarding their arterial
disease, but also regarding all other possible systemic re-
percussions.
Table 2 - Variation in the change in maximum walking
distance (MWD) during follow-up
Stable Progression
Delta 1 (meters) 59 (range, -50 to 344) 50 (range, 0 to 300)
Delta 2 (meters) 0 (range, -57.5 to 157.5)
Delta 3 (meters) 5 (range, 0 to 150)
P = 0.47 between Delta 1 of stable and progression groups; P = 0.83 between
Delta 1, 2, and 3 of the progression group
Table 1 - Demographic data of both groups
Stable Progression
n 324 40
Male sex % 63 45 *
Mean age (years) 64 (54 – 72) 64.5 (59.8 – 69)
Follow-up length (days) 276 277
age expressed as median (interquartile range); * P = 0.417, χ2 = 3.94
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RESUMO
Rosoky RMA, Wolosker N, Puech-Leão P. Desempenho
de pacientes com claudicação intermitente submetidos
ao treinamento físico em resposta ao agravamento da
doença arterial. Estudo retrospectivo de coorte. Clinics.
2006;61(6):535-8.
OBJETIVO: Estudo retrospectivo de coorte para
investigar o desfecho clínico de pacientes com claudi-
cação intermitente submetidos a treinamento físico nos
quais houve um agravamento da arteriopatia.
MÉTODO: Trezentos e sessenta e quatro pacientes
com claudicação que apresentavam obstruções fêmoro-
poplíteas ou tíbio-peroneiras em ao menos um dos
membros inferiores e que não tinham obstrução de aorta
ou de ambas artérias ilíacas foram incluídos. Quarenta
pacientes desenvolveram novas estenoses em segmentos
arteriais previamente poupados (confirmadas por duplex
scan), que eram proximais às lesões pré-existentes, e
constituiram o grupo progressivo, em contraste com o
grupo estável, de pacientes que não apresentou essa
piora da doença. O tempo de seguimento foi de 276 e
277 dias para os grupos estável e progressivo,
respectivamente. Todos os pacientes passaram por um
programa não supervisionado de caminhadas
submáximas 4 vezes por semana. Alterações na
distância máxima de claudicação num teste de esteira
com carga progressiva foram avaliadas durante o
seguimento, com interesse especial nos períodos entre
a admissão e o diagnóstico da progressão da
arteriopatia e o final do acompanhamento.
RESULTADOS: A performance não foi significantemente
diferente entre ambos grupos, considerando todo o período
de seguimento. Ademais, os claudicantes que evoluíram
com progressão da arteriopatia não apresentaram, em
nenhum momento de seu seguimento, qualquer redução
da distância máxima de caminhada em resposta ao
desenvolvimento de novas lesões arteriais.
CONCLUSÃO: A piora da doença arterial periférica em
claudicantes submetidos ao treinamento físico, manifestada
por novas oclusões em segmentos arteriais proximais
previamente poupados, não implica necessariamente numa
piora da distância de claudicação.
UNITERMOS: Claudicação intermitente. Desfecho do
tratamento. Exercício. Progressão da doença. Doença ar-
terial obstrutiva periférica.
REFERENCES
1. The TASC Working Group. Management of peripheral arterial disease
(PAD); Transatlantic Inter-Society Consensus (TASC). J Vasc Surg.
2000;31:S1-288.
2. Walsh DB, Gilbertson JJ, Zwolak RM, Besso S, Edelman GC, Schneider
JR, et al. The natural history of superficial femoral stenoses. J Vasc
Surg. 1991;14:299-304.
3. Coran AG, Warren R. Arteriographic changes in femoropopliteal
arteriosclerosis obliterans. A five-year follow-up study. N Eng J Med.
1966;274:643-7.
4. Gardner AW, Skinner JS, Cantwell BW, Smith K. Progressive vs. single-
stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc.
1991;23:402-8.
5. Jelnes R, Gaardsting O, Jensen KH, Bækgaard N, Tønnesen KH. Fate
in intermittent claudication: outcome and risk factors. Br Med J.
1986;293:1137-40.
6. Aquino R, Johnnides C, Makaroun M, Whittle JC, Muluk VS, Kelley
ME, et al. Natural history of claudication: Long-term serial follow-up
study of 1244 claudicants. J Vasc Surg. 2001;34:962-70.
7. Wolosker N, Nakano L, Rosoky RA, Puech-Leão P. Evaluation of
walking capacity over time in 500 patients with intermittent claudication
who underwent clinical treatment. Arch Int Med. 2003;163:2296-300.
8. Hiatt WR, Regensteiner JG, Wolfel EE, Carry MR, Brass EP. Effect of
exercise training on skeletal muscle histology and metabolism in
peripheral arterial disease. J Appl Physiol. 1996;81:780-8.
9. Ernst EE. Matrai A. Intermittent claudication, exercise and blood
rheology. Circulation. 1987;76:1110-4.
10. Rosoky RMA, Wolosker N, Muraco BN, Puech-Leão P. Ground reaction
force pattern in limbs with intermittent claudication. Eur J Vasc Endovasc
Surg. 2000;20:254-9.
11. Womack CJ, Sieminski DJ, Katzel LI, Yataco A, Gardner AW. Improved
walking economy in patients with peripheral arterial occlusive disease.
Med Sci Sports Exerc. 1997;29:1286-90.
